Pfizer, Eli Lilly, and Abbott Laboratories are competing in the global biopharmaceutical market and are being tracked by MarketBeat stock screeners.
2 reports, 2 independent
Updated Wed 00:00
No new developments lately
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pfizer, Eli Lilly, and Abbott Laboratories are competing in the global biopharmaceutical market and are being tracked by MarketBeat stock screeners.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
-
Eli Lilly and Company
American pharmaceutical company
-
Abbott Laboratories
American global health care and medical device products company
Related events
- MarketBeat is providing analyst ratings and tracking the competitive landscape between healthcare companies Pfizer and Lyra Therapeutics.
- FDA approval clears the path for drug market entry, driving future regulatory focus for major pharmaceutical companies.
- Eli Lilly and Novo Nordisk are competing for market share in the weight loss drug sector.
- Pfizer is jointly marketing the drug Eliquis.
- Bristol-Myers Squibb and Pfizer are co-marketing Eliquis, while both companies are noted as dividend payers.